Showing results (21-30 of 1,026) with videos related to
Sort By:
Pageof 103
Cancer Treatment Reviews|June 23, 2012
Optimal management of elderly patients with glioblastomaNormand Laperriere, Michael Weller, Roger Stupp, et al.Nature Reviews. Neurology|December 10, 2009
MGMT promoter methylation in malignant gliomas: ready for personalized medicine?Michael Weller, Roger Stupp, Guido Reifenberger, et al.Expert Review of Anticancer Therapy|August 24, 2006
Temozolomide: a milestone in neuro-oncology and beyond?Nicole Mutter, Roger StuppCurrent Opinion in Neurology|September 30, 2009
Primetime for antiangiogenic therapyGhazaleh Tabatabai, Roger StuppNeuro-Oncology|October 26, 2012
Personalized care in neuro-oncology coming of age: why we need MGMT and 1p/19q testing for malignant glioma patients in clinical practiceMichael Weller, Roger Stupp, Monika E Hegi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2008
Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activityMonika E Hegi, Lili Liu, James G Herman, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2021
Temporal Muscle Thickness as a Prognostic Marker in Patients with Newly Diagnosed Glioblastoma: Translational Imaging Analysis of the CENTRIC EORTC 26071-22072 and CORE TrialsJulia Furtner, Michael Weller, Michael Weber, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2019
Overcoming the Blood-Brain Barrier with an Implantable Ultrasound DeviceAdam M Sonabend, Roger StuppJournal of Neuro-Oncology|February 10, 2018
Do statins, ACE inhibitors or sartans improve outcome in primary glioblastoma?Caroline Happold, Thierry Gorlia, L Burt Nabors, et al.Current Opinion in Neurology|August 25, 2010
Epilepsy in brain tumor patientsAndrea O Rossetti, Roger StuppPageof 103